Dizlin Pharmaceuticals has obtained a “Decision to Grant” by the European Patent Office for Infudopa SubC™, a new potential treatment for Parkinson’s disease
Dizlin Pharmaceuticals announced today that the European Patent Office (EPO) has issued a Decision to Grant a European patent pursuant to Article 97(1) EPC following examination of European patent application No. 18730319.3. The mention of the Grant was published in…
